Viral Kinetics in HCV Clearance in Subjects With Hemophilia

NCT01704521 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C
Hemophilia

Interventions

DRUG: PegInterferon
DRUG: Ribavirin
DRUG: Telaprevir

Sponsor

Kenneth Sherman

Collaborators

[object Object]
[object Object]
[object Object]